Loading clinical trials...
Loading clinical trials...
Multi-center study of specimens from subjects presenting to the flow cytometry laboratory as part of their standard of care for hematological diseases work-up.
Multi-center study of specimens from subjects presenting for flow cytometry immunophenotyping as part of their standard of care for hematological diseases work-up. Residual specimens will be tested using the ClearLLab Panels to determine the presence or absence of an abnormal phenotype and compare results to clinical impression (hematological malignancy or non-malignancy).
Age
All ages
Sex
ALL
Healthy Volunteers
No
NeoGenomics Laboratories, Inc.
Fort Myers, Florida, United States
Calgary Laboratory Services
Calgary, Alberta, Canada
London Health Sciences Center
London, Ontario, Canada
Munich Leukemia Laboratory
Munich, Germany
Start Date
November 14, 2017
Primary Completion Date
April 27, 2018
Completion Date
April 27, 2018
Last Updated
July 13, 2018
482
ACTUAL participants
Flow Cytometry
DIAGNOSTIC_TEST
Lead Sponsor
Beckman Coulter, Inc.
NCT06880913
NCT04003012
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT00849147